MEFFX
Price
$15.57
Change
-$0.00 (-0.00%)
Updated
Sep 18 closing price
PAMCX
Price
$102.55
Change
-$0.00 (-0.00%)
Updated
Sep 18 closing price
Ad is loading...

MEFFX vs PAMCX

Header iconMEFFX vs PAMCX Comparison
Open Charts MEFFX vs PAMCXBanner chart's image
MassMutual Mid Cap Growth R4
Price$15.57
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth Adv
Price$102.55
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
MEFFX vs PAMCX Comparison Chart
Loading...
VS
MEFFX vs. PAMCX commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEFFX is a StrongBuy and PAMCX is a StrongBuy.

FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 31B vs. MEFFX (5.05B). MEFFX (0.00) and PAMCX (0.00) have matching dividends . MEFFX was incepted earlier than PAMCX: MEFFX (10 years) vs PAMCX (24 years). MEFFX is a more actively managed with annual turnover of: 32.00 vs. PAMCX (21.70). MEFFX has a lower initial minimum investment than PAMCX: MEFFX (0) vs PAMCX (2500). PAMCX annual gain was more profitable for investors over the last year : 10.53 vs. MEFFX (9.95). PAMCX return over 5 years is better than : 11.14 vs. MEFFX (-22.02).
MEFFXPAMCXMEFFX / PAMCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years24 years-
Gain YTD8.7997.936111%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets5.05B31B16%
Annual Yield % from dividends0.000.00-
Returns for 1 year9.9510.5394%
Returns for 3 years-41.23-16.76246%
Returns for 5 years-22.0211.14-198%
Returns for 10 years-12.2334.74-35%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TFX241.530.09
+0.04%
Teleflex
CGNT6.71-0.10
-1.47%
Cognyte Software Ltd
LFST6.72-0.11
-1.61%
LifeStance Health Group
QLGN0.17N/A
-2.03%
Qualigen Therapeutics
CRDF2.47-0.07
-2.76%
Cardiff Oncology